Brookfield Asset Management Inc. Abbott Laboratories Transaction History

Brookfield Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$100.78 - $112.29 $384,475 - $428,386	-3,815 Reduced 48.38%	4,071 $443,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $384,475 - $428,386	-3,815 Reduced 48.38%	4,071 $443,000
Q1 2023 Sep 25, 2023	BUY	$96.86 - $114.01 $369,520 - $434,948	3,815 Added 93.71%	7,886 $798,000
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $763,837 - $899,082	7,886 New	7,886 $798,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $1.71 Million - $2.02 Million	15,729 Added 151.34%	26,122 $3.13 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $2.63 Million - $2.86 Million	-25,017 Reduced 70.65%	10,393 $1.14 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $440,238 - $534,637	4,804 Added 15.7%	35,410 $3.85 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $2.34 Million - $3 Million	30,606 New	30,606 $2.8 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.